Table 3.
Recurrence of hepatocellular carcinoma and death after curative resection
| Recurrence | |
|---|---|
| Intrahepatic recurrence |
222 (76.6%) |
| Extrahepatic recurrence |
68 (23.4%) |
|
Main treatment for recurrence |
|
| Transplantation |
10 (3.4%) |
| Repeat resection |
29 (9.8%) |
| Local ablation therapy |
29 (9.8%) |
| TACE |
172 (58.1%) |
| Chemotherapy |
26 (4.3%) |
| Radiation therapy |
16 (5.4%) |
|
Cause of death |
|
| Recurrent HCC |
182 (80.9%) |
| Complication of liver cirrhosis without recurrence |
25 (11.1%) |
| Unrelated (including perioperative death) | 18 (8.0%) |
HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.